Table 4 Pathological cases
| Â | Reference N = 36 | Clozapine N = 6 | Risperidone N = 20 | Olanzapine N = 31 | Quetiapine N = 19 | chi-s | df | P |
|---|---|---|---|---|---|---|---|---|
Hyperglycaemia (110 ≤ glycaemia ≤ 125.9 mg/dl) | 1 (3%) | 2 (33%) | 2 (10%) | 2(7%) | 4 (22%) | 8.9 | 4 | 0.06 |
Diabetes (glycaemia ≥126 mg/dl) |  |  | 1(5%) | 2(6.5%) | 1(5%) | 2.6 | 4 | 0.6 |
Hypercholesterolemia (cholesterolemia ≥200 mg/dl) | 22 (61%) | 4 (67%) | 10 (50%) | 18 (58%) | 16 (84%) | 5.5 | 4 | 0.241 |
Hypertriglyceridemia (triglyceridemia ≥150 mg/dl) | 5 (14%) | 5 (83%) | 9 (45%) | 7 (23%) | 10 (53%) | 18.2 | 4 | 0.001 |
Overweight (25 ≤ BMI ≤ 29.9) |  | 1 (17)% | 7 (39%) | 13 (42%) | 11 (58%) | 4.5 | 3 | 0.2 |
Obesity (BMI≥ 30) |  | 5 (83%) | 7 (39%) | 6 (19%) | 6 (32%) | 15.8 | 3 | 0.015 |